Snapshot
The global Recombinant Peptides market size is estimated at xxx million USD with a CAGR xx% from 2015-2019 and is expected to reach xxx Million USD in 2020 with a CAGR xx% from 2020 to 2025. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Recombinant Peptides by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Glucagon
Calcitonin
Others
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Sandoz Pharma
Stada Arzneimittel
Amgen
Hospira
Actavis
Cipla Ltd.
Wockhardt Ltd.
Biocon Ltd.
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Oncology
Blood Disorders
Infectious Diseases
Autoimmune Diseases
Others
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)

Table of Content

1 Industry Overview
1.1 Recombinant Peptides Industry
Figure Recombinant Peptides Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Recombinant Peptides
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Recombinant Peptides
1.2.2 Downstream
Table Application Segment of Recombinant Peptides
Table Global Recombinant Peptides Market 2015-2025, by Application, in USD Million
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Recombinant Peptides Market by Type
3.1 By Type
3.1.1 Glucagon
Table Major Company List of Glucagon
3.1.2 Calcitonin
Table Major Company List of Calcitonin
3.1.3 Others
Table Major Company List of Others
3.2 Market Size
Table Global Recombinant Peptides Market 2015-2019, by Type, in USD Million
Figure Global Recombinant Peptides Market Growth 2015-2019, by Type, in USD Million
Table Global Recombinant Peptides Market 2015-2019, by Type, in Volume
Figure Global Recombinant Peptides Market Growth 2015-2019, by Type, in Volume
3.3 Market Forecast
Table Global Recombinant Peptides Market Forecast 2020-2025, by Type, in USD Million
Table Global Recombinant Peptides Market Forecast 2020-2025, by Type, in Volume
4 Major Companies List
4.1 Sandoz Pharma (Company Profile, Sales Data etc.)
4.1.1 Sandoz Pharma Profile
Table Sandoz Pharma Overview List
4.1.2 Sandoz Pharma Products & Services
4.1.3 Sandoz Pharma Business Operation Conditions
Table Business Operation of Sandoz Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Stada Arzneimittel (Company Profile, Sales Data etc.)
4.2.1 Stada Arzneimittel Profile
Table Stada Arzneimittel Overview List
4.2.2 Stada Arzneimittel Products & Services
4.2.3 Stada Arzneimittel Business Operation Conditions
Table Business Operation of Stada Arzneimittel (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Amgen (Company Profile, Sales Data etc.)
4.3.1 Amgen Profile
Table Amgen Overview List
4.3.2 Amgen Products & Services
4.3.3 Amgen Business Operation Conditions
Table Business Operation of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Hospira (Company Profile, Sales Data etc.)
4.4.1 Hospira Profile
Table Hospira Overview List
4.4.2 Hospira Products & Services
4.4.3 Hospira Business Operation Conditions
Table Business Operation of Hospira (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Actavis (Company Profile, Sales Data etc.)
4.5.1 Actavis Profile
Table Actavis Overview List
4.5.2 Actavis Products & Services
4.5.3 Actavis Business Operation Conditions
Table Business Operation of Actavis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Cipla Ltd. (Company Profile, Sales Data etc.)
4.6.1 Cipla Ltd. Profile
Table Cipla Ltd. Overview List
4.6.2 Cipla Ltd. Products & Services
4.6.3 Cipla Ltd. Business Operation Conditions
Table Business Operation of Cipla Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Wockhardt Ltd. (Company Profile, Sales Data etc.)
4.7.1 Wockhardt Ltd. Profile
Table Wockhardt Ltd. Overview List
4.7.2 Wockhardt Ltd. Products & Services
4.7.3 Wockhardt Ltd. Business Operation Conditions
Table Business Operation of Wockhardt Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Biocon Ltd. (Company Profile, Sales Data etc.)
4.8.1 Biocon Ltd. Profile
Table Biocon Ltd. Overview List
4.8.2 Biocon Ltd. Products & Services
4.8.3 Biocon Ltd. Business Operation Conditions
Table Business Operation of Biocon Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Recombinant Peptides Sales Revenue 2015-2019, by Company, in USD Million
Table Global Recombinant Peptides Sales Revenue Share 2015-2019, by Company, in USD Million
Figure Global Recombinant Peptides Sales Revenue Share in 2019, by Company, in USD Million
Table Global Recombinant Peptides Sales Volume 2015-2019, by Company, in Volume
Table Global Recombinant Peptides Sales Volume Share 2015-2019, by Company, in Volume
Figure Global Recombinant Peptides Sales Volume Share in 2019, by Company, in Volume
5.2 Regional Market by Company
Figure North America Recombinant Peptides Market Concentration, in 2019
Figure Europe Recombinant Peptides Market Market Concentration, in 2019
Figure Asia-Pacific Recombinant Peptides MMarket Concentration, in 2019
Figure South America Recombinant Peptides Market Concentration, in 2019
Figure Middle East & Africa Recombinant Peptides Market Concentration, in 2019
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Oncology
Figure Recombinant Peptides Demand in Oncology, 2015-2019, in USD Million
Figure Recombinant Peptides Demand in Oncology, 2015-2019, in Volume
6.1.2 Demand in Blood Disorders
Figure Recombinant Peptides Demand in Blood Disorders, 2015-2019, in USD Million
Figure Recombinant Peptides Demand in Blood Disorders, 2015-2019, in Volume
6.1.3 Demand in Infectious Diseases
Figure Recombinant Peptides Demand in Infectious Diseases, 2015-2019, in USD Million
Figure Recombinant Peptides Demand in Infectious Diseases, 2015-2019, in Volume
6.1.4 Demand in Autoimmune Diseases
Figure Recombinant Peptides Demand in Autoimmune Diseases, 2015-2019, in USD Million
Figure Recombinant Peptides Demand in Autoimmune Diseases, 2015-2019, in Volume
6.1.5 Demand in Others
Figure Recombinant Peptides Demand in Others, 2015-2019, in USD Million
Figure Recombinant Peptides Demand in Others, 2015-2019, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Recombinant Peptides Demand Forecast 2020-2025, by Application, in USD Million
Figure Recombinant Peptides Market Growth 2020-2025, by Application, in USD Million
Figure Recombinant Peptides Market Share in 2025, by Application, in USD Million
Table Recombinant Peptides Demand Forecast 2020-2025, by Application, in Volume
Table Recombinant Peptides Market Growth 2020-2025, by Application, in Volume
Table Recombinant Peptides Market Share in 2025, by Application, in Volume
7 Region Operation
7.1 Regional Production
Table Recombinant Peptides Production 2015-2019, by Region, in USD Million
Table Recombinant Peptides Production 2015-2019, by Region, in Volume
7.2 Regional Market
Table Global Recombinant Peptides Market 2015-2019, by Region, in USD Million
Table Global Recombinant Peptides Market Share 2015-2019, by Region, in USD Million
Table Global Recombinant Peptides Market 2015-2019, by Region, in Volume
Table Global Recombinant Peptides Market Share 2015-2019, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Recombinant Peptides Market Size and Growth 2015-2019, in USD Million
Figure North America Recombinant Peptides Market Size and Growth 2015-2019, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Recombinant Peptides Market Size 2015-2019, by Country, in USD Million
Table North America Recombinant Peptides Market Size 2015-2019, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Recombinant Peptides Market Size and Growth 2015-2019, in USD Million
Figure Europe Recombinant Peptides Market Size and Growth 2015-2019, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Recombinant Peptides Market Size 2015-2019, by Country, in USD Million
Table Europe Recombinant Peptides Market Size 2015-2019, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Recombinant Peptides Market Size and Growth 2015-2019, in USD Million
Figure Asia-Pacific Recombinant Peptides Market Size and Growth 2015-2019, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Recombinant Peptides Market Size 2015-2019, by Country, in USD Million
Table Asia-Pacific Recombinant Peptides Market Size 2015-2019, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Recombinant Peptides Market Size and Growth 2015-2019, in USD Million
Figure South America Recombinant Peptides Market Size and Growth 2015-2019, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Recombinant Peptides Market Size 2015-2019, by Country, in USD Million
Table South America Recombinant Peptides Market Size 2015-2019, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Recombinant Peptides Market Size and Growth 2015-2019, in USD Million
Figure Middle East & Africa Recombinant Peptides Market Size and Growth 2015-2019, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Recombinant Peptides Market Size 2015-2019, by Country, in USD Million
Table Middle East & Africa Recombinant Peptides Market Size 2015-2019, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Recombinant Peptides Market Forecast 2020-2025, by Region, in USD Million
Table Recombinant Peptides Market Forecast 2020-2025, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion

List of Tables

List of Table

List of Table

Table Upstream Segment of Recombinant Peptides
Table Application Segment of Recombinant Peptides
Table Global Recombinant Peptides Market 2015-2025, by Application, in USD Million
Table Major Company List of Calcitonin
Table Major Company List of Others
Table Global Recombinant Peptides Market 2015-2019, by Type, in USD Million
Table Global Recombinant Peptides Market 2015-2019, by Type, in Volume
Table Global Recombinant Peptides Market Forecast 2020-2025, by Type, in USD Million
Table Global Recombinant Peptides Market Forecast 2020-2025, by Type, in Volume
Table Sandoz Pharma Overview List
Table Business Operation of Sandoz Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Stada Arzneimittel Overview List
Table Business Operation of Stada Arzneimittel (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Amgen Overview List
Table Business Operation of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Hospira Overview List
Table Business Operation of Hospira (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Actavis Overview List
Table Business Operation of Actavis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Cipla Ltd. Overview List
Table Business Operation of Cipla Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Wockhardt Ltd. Overview List
Table Business Operation of Wockhardt Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Biocon Ltd. Overview List
Table Business Operation of Biocon Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Recombinant Peptides Sales Revenue 2015-2019, by Company, in USD Million
Table Global Recombinant Peptides Sales Revenue Share 2015-2019, by Company, in USD Million
Table Global Recombinant Peptides Sales Volume 2015-2019, by Company, in Volume
Table Global Recombinant Peptides Sales Volume Share 2015-2019, by Company, in Volume
Table Regional Demand Comparison List
Table Major Application in Different Regions
Table Recombinant Peptides Demand Forecast 2020-2025, by Application, in USD Million
Table Recombinant Peptides Demand Forecast 2020-2025, by Application, in Volume
Table Recombinant Peptides Market Growth 2020-2025, by Application, in Volume
Table Recombinant Peptides Market Share in 2025, by Application, in Volume
Table Recombinant Peptides Production 2015-2019, by Region, in USD Million
Table Recombinant Peptides Production 2015-2019, by Region, in Volume
Table Global Recombinant Peptides Market 2015-2019, by Region, in USD Million
Table Global Recombinant Peptides Market Share 2015-2019, by Region, in USD Million
Table Global Recombinant Peptides Market 2015-2019, by Region, in Volume
Table Global Recombinant Peptides Market Share 2015-2019, by Region, in Volume
Table North America Recombinant Peptides Market Size 2015-2019, by Country, in USD Million
Table North America Recombinant Peptides Market Size 2015-2019, by Country, in Volume
Table Europe Recombinant Peptides Market Size 2015-2019, by Country, in USD Million
Table Europe Recombinant Peptides Market Size 2015-2019, by Country, in Volume
Table Asia-Pacific Recombinant Peptides Market Size 2015-2019, by Country, in USD Million
Table Asia-Pacific Recombinant Peptides Market Size 2015-2019, by Country, in Volume
Table South America Recombinant Peptides Market Size 2015-2019, by Country, in USD Million
Table South America Recombinant Peptides Market Size 2015-2019, by Country, in Volume
Table Middle East & Africa Recombinant Peptides Market Size 2015-2019, by Country, in USD Million
Table Middle East & Africa Recombinant Peptides Market Size 2015-2019, by Country, in Volume
Table Recombinant Peptides Market Forecast 2020-2025, by Region, in USD Million
Table Recombinant Peptides Market Forecast 2020-2025, by Region, in Volume
Table Price Factors List

List of Figures

List of Figure

Figure Recombinant Peptides Industry Chain Structure
Figure Global Recombinant Peptides Market Growth 2015-2019, by Type, in USD Million
Figure Global Recombinant Peptides Market Growth 2015-2019, by Type, in Volume
Figure Global Recombinant Peptides Sales Revenue Share in 2019, by Company, in USD Million
Figure Global Recombinant Peptides Sales Volume Share in 2019, by Company, in Volume
Figure North America Recombinant Peptides Market Concentration, in 2019
Figure Europe Recombinant Peptides Market Market Concentration, in 2019
Figure Asia-Pacific Recombinant Peptides MMarket Concentration, in 2019
Figure South America Recombinant Peptides Market Concentration, in 2019
Figure Middle East & Africa Recombinant Peptides Market Concentration, in 2019
Figure Recombinant Peptides Demand in Oncology, 2015-2019, in USD Million
Figure Recombinant Peptides Demand in Oncology, 2015-2019, in Volume
Figure Recombinant Peptides Demand in Blood Disorders, 2015-2019, in USD Million
Figure Recombinant Peptides Demand in Blood Disorders, 2015-2019, in Volume
Figure Recombinant Peptides Demand in Infectious Diseases, 2015-2019, in USD Million
Figure Recombinant Peptides Demand in Infectious Diseases, 2015-2019, in Volume
Figure Recombinant Peptides Demand in Autoimmune Diseases, 2015-2019, in USD Million
Figure Recombinant Peptides Demand in Autoimmune Diseases, 2015-2019, in Volume
Figure Recombinant Peptides Demand in Others, 2015-2019, in USD Million
Figure Recombinant Peptides Demand in Others, 2015-2019, in Volume
Figure Recombinant Peptides Market Growth 2020-2025, by Application, in USD Million
Figure Recombinant Peptides Market Share in 2025, by Application, in USD Million
Figure North America Recombinant Peptides Market Size and Growth 2015-2019, in USD Million
Figure North America Recombinant Peptides Market Size and Growth 2015-2019, in Volume
Figure Europe Recombinant Peptides Market Size and Growth 2015-2019, in USD Million
Figure Europe Recombinant Peptides Market Size and Growth 2015-2019, in Volume
Figure Asia-Pacific Recombinant Peptides Market Size and Growth 2015-2019, in USD Million
Figure Asia-Pacific Recombinant Peptides Market Size and Growth 2015-2019, in Volume
Figure South America Recombinant Peptides Market Size and Growth 2015-2019, in USD Million
Figure South America Recombinant Peptides Market Size and Growth 2015-2019, in Volume
Figure Middle East & Africa Recombinant Peptides Market Size and Growth 2015-2019, in USD Million
Figure Middle East & Africa Recombinant Peptides Market Size and Growth 2015-2019, in Volume
Figure Marketing Channels Overview

Asia Pacific Bioprocess Technology Market 2023-2033 by Product (Instruments, Consumables and Accessories), Process (Upstream, Downstream), Procedure, Application (Recombinant Proteins, Antibiotics, Biosimilars, mAbs, Others), End User (Biopharma Companies, CMOs, Institutes, CROs), and Country: Trend Forecast and Growth Opportunity...

Asia Pacific bioprocess technology market will grow by 15.0% annually with a total addressable market cap of $170.71 billion over 2024-2033. The growth is driven an increasing prevalence of chronic diseases, the widespread use of bioprocess technology, rising expenditures on R&D in the biotechnology...

Europe Bioprocess Technology Market 2023-2033 by Product (Instruments, Consumables and Accessories), Process (Upstream, Downstream), Procedure, Application (Recombinant Proteins, Antibiotics, Biosimilars, mAbs, Others), End User (Biopharma Companies, CMOs, Institutes, CROs), and Country: Trend Forecast and Growth Opportunity...

Europe bioprocess technology market was valued at $6.56 billion in 2023 and will grow by 13.7% annually over 2023-2033. The growth is driven an increasing prevalence of chronic diseases, the widespread use of bioprocess technology, rising expenditures on R&D in the biotechnology sector, ongoing tech...

North America Bioprocess Technology Market 2023-2033 by Product (Instruments, Consumables and Accessories), Process (Upstream, Downstream), Procedure, Application (Recombinant Proteins, Antibiotics, Biosimilars, mAbs, Others), End User (Biopharma Companies, CMOs, Institutes, CROs), and Country: Trend Forecast and Growth Opportunity...

North America bioprocess technology market is projected to grow by 13.3% annually in the forecast period and reach $29.68 billion by 2033. The growth is driven an increasing prevalence of chronic diseases, the widespread use of bioprocess technology, rising expenditures on R&D in the biotechnology s...

Global Bioprocess Technology Market 2023-2033 by Product (Instruments, Consumables and Accessories), Process (Upstream, Downstream), Procedure, Application (Recombinant Proteins, Antibiotics, Biosimilars, mAbs, Others), End User (Biopharma Companies, CMOs, Institutes, CROs), and Region: Trend Forecast and Growth Opportunity...

Global bioprocess technology market will reach $88.39 billion by 2033, growing by 13.8% annually over 2023-2033. The growth is driven an increasing prevalence of chronic diseases, the widespread use of bioprocess technology, rising expenditures on R&D in the biotechnology sector, ongoing technologic...

2023-2028 Global and Regional Recombinant Human Endostatin Industry Status and Prospects Professional Market Research Report Standard Version...

The global Recombinant Human Endostatin market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players...

2023-2028 Global and Regional Recombinant Human Proteins Industry Status and Prospects Professional Market Research Report Standard Version...

The global Recombinant Human Proteins market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players i...

2023-2028 Global and Regional Recombinant Vector Vaccines Industry Status and Prospects Professional Market Research Report Standard Version...

The global Recombinant Vector Vaccines market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players ...

2023-2028 Global and Regional Recombinant Peptides Industry Status and Prospects Professional Market Research Report Standard Version...

The global Recombinant Peptides market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this...

2023-2028 Global and Regional Recombinant Peptide Industry Status and Prospects Professional Market Research Report Standard Version...

The global Recombinant Peptide market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this ...

2023-2028 Global and Regional Peptides Biosimilars Industry Status and Prospects Professional Market Research Report Standard Version...

The global Peptides Biosimilars market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this...